COMPANY
USFDA completes inspection at Laurus Labs’ API manufacturing facilities
Apr-19-2024

United States Food & Drug Administration (USFDA) has completed inspection at Laurus Labs’ API manufacturing facilities Unit-1 and Unit-3, Parawada, Anakapalli (Visakhapatnam), Andhra Pradesh. The inspection was conducted from April 15, 2024 to April 19, 2024. The inspection was successfully closed without any 483 observations.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

  RELATED NEWS >>